Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library

BACKGROUND: Casein kinase 2 (CK2) is dysregulated in various human cancers and is a promising target for cancer therapy. To date, there is no small molecular CK2 inhibitor in clinical trial yet. With the aim to identify novel CK2 inhibitors, we screened a natural product library. METHODS: We adopted...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hung, Ming-Szu, Xu, Zhidong, Lin, Yu-Ching, Mao, Jian-Hua, Yang, Cheng-Ta, Chang, Pey-Jium, Jablons, David M, You, Liang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2009
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2696466/
https://ncbi.nlm.nih.gov/pubmed/19419583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-135
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak